Literature DB >> 6773422

myo-Inositol transport in renal brush border vesicles and it inhibition by D-glucose.

M R Hammerman, B Sacktor, W H Daughaday.   

Abstract

We examined the mechanism of myo-inositol uptake by rabbit renal proximal tubule brush border membrane vesicles and characterized the relationship between the transports of myo-inositol and D-glucose. A 100 mM Na+ electrochemical gradient (extravesicular medium > intravesicular medium) stimulated the initial rate of myo-inositol uptake 20- to 60-fold. Other cation gradients were ineffective. The Na+ myo-inositol co-transport system was shown to be electrogenic. The Na+ electrochemical gradient-dependent uptake of myo-inositol saturated at about 1 mM myo-inositol, with an apparent Km of 94 micro M at an initial 100 mM Na+ gradient. D-Glucose was an inhibitor of the Na+ gradient-dependent uptake of myo-inositol. D-Glucose, but not L-glucose, elicited accelerative exchange diffusion of myo-inositol. myo-Inositol did not significantly inhibit the Na+ gradient-dependent transport of D-glucose. We suggest that D-glucose inhibits myo-inositol uptake by dissipating the membrane potential and sharing the myo-inositol carrier. The inhibition of myo-inositol transport across the brush border membrane by D-glucose explains how glycosuria could produce inosituria in patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773422     DOI: 10.1152/ajprenal.1980.239.2.F113

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.

Authors:  Hao-Han Chang; Bernard Choong; Anthony R J Phillips; Kerry M Loomes
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-24

2.  Osmoregulatory changes in myo-inositol transport by renal cells.

Authors:  T Nakanishi; R J Turner; M B Burg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Impaired ability to increase water excretion in mice lacking the taurine transporter gene TAUT.

Authors:  Dan Yang Huang; Krishna M Boini; Philipp A Lang; Florian Grahammer; Michael Duszenko; Birgit Heller-Stilb; Ulrich Warskulat; Dieter Häussinger; Florian Lang; Volker Vallon
Journal:  Pflugers Arch       Date:  2005-10-26       Impact factor: 3.657

4.  Feedback inhibition of aldose reductase gene expression in rat renal medulla. Galactitol accumulation reduces enzyme mRNA levels and depletes cellular inositol content.

Authors:  C Bondy; B D Cowley; S L Lightman; P F Kador
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

5.  myo-Inositol is an osmolyte in rat liver macrophages (Kupffer cells) but not in RAW 264.7 mouse macrophages.

Authors:  U Warskulat; C Weik; D Häussinger
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

6.  Active transport of myo-inositol in rat pancreatic islets.

Authors:  T J Biden; C B Wollheim
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

7.  In vivo use of neutral radiolabelled molecular probes to evaluate blood-ocular barrier integrity in normal and streptozotocin-diabetic rats.

Authors:  J DiMattio
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

8.  Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect.

Authors:  D A Greene; S A Lattimer
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

9.  Taurine behaves as an osmolyte in Madin-Darby canine kidney cells. Protection by polarized, regulated transport of taurine.

Authors:  S Uchida; T Nakanishi; H M Kwon; A S Preston; J S Handler
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  Expression of the sodium-myo-inositol cotransporter SMIT2 at the apical membrane of Madin-Darby canine kidney cells.

Authors:  Pierre Bissonnette; Michael J Coady; Jean-Yves Lapointe
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.